CHOP is one of 42 institutions selected by the Patient-Centered Outcomes Research Institute (PCORI) as part of the $50 million initiative.

Every year, surgeons, anesthesiologists, social workers, and other healthcare providers from hospitals across the world gather with a common goal: to bring expert care to patients who travel from near and far seeking hope.

Sophie Foss, PhD, has joined the CHOP Congenital Hyperinsulinism Center as its neuropsychologist. See how she can help your child.

Nurse coordinators at the Congenital Hyperinsulinism Center assist patient families before the first appointment and through admission and follow-up.

The drug, omaveloxolone, is a once-a-day pill that will help improve neurological function and slow progression of the neurodegenerative disease.

Late-onset sepsis is a significant cause of morbidity and mortality among very preterm infants.

Check out a new infographic highlighting three important points related to aluminum in vaccines, and find links to the updated 2023 immunization schedules.

In this issue of Parents PACK, we take a closer look at COVID-19 and kids, including disease complications, immunity after natural infection, vaccination rates, and safety of the COVID-19 vaccine.

Translational findings in new models of SURF1 mitochondrial disease also suggest that two drugs, already FDA-approved for other conditions, may prevent neurological decompensation in Leigh syndrome patients.

Check out important takeaways from a descriptive analysis of COVID-19 deaths based on WHO data sources. You’ll also find materials from the “We Can Do This” campaign for educating the public about COVID-19.